Xisheng Weng Selected Research

Joint Diseases (Joint Disease)

6/2021	Mid-Term Outcome of Total Hip Arthroplasty in Patients With Progressive Pseudorheumatoid Dysplasia.
1/2019	Bone-strengthening supplement (BSP) promotes bone and cartilage repair, for the treatment of Osteonecrosis of Femoral Head: an MRI-based study.
12/2018	Comparison of 90-Day Complication Rates and Cost Between Single and Multiple Joint Procedures for End-Stage Arthropathy in Patients with Hemophilia.
8/2018	Ilizarov technique in an adolescent patient with progressive pseudorheumatoid dysplasia: A case report.
7/2018	Hemophilic arthropathy in a patient with multi-joint replacement: A case report and literature review.
1/2018	Simultaneous bilateral total knee arthroplasty in patients with end-stage hemophilic arthropathy: a mean follow-up of 6 years.
1/2018	Emerging Role of Exosomes in the Joint Diseases.
1/2017	Efficacy of a modified coagulation factor substitution for total hip arthroplasty in patients with end-stage haemophilic arthropathy.
2/2015	[Postoperative complications and revision surgery following primary total knee arthroplasty after midterm follow-up].
3/2012	[Effectiveness of multiple joint arthroplasty in treating lower limb joint disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xisheng Weng Research Topics

Disease

16	Osteoarthritis 10/2022 - 09/2002
13	Osteonecrosis (Kienbock's Disease) 01/2021 - 07/2013
13	Pain (Aches) 01/2021 - 01/2013
10	Joint Diseases (Joint Disease) 06/2021 - 03/2012
9	Wounds and Injuries (Trauma) 08/2022 - 09/2002
9	Neoplasms (Cancer) 01/2022 - 07/2015
8	Congenital Abnormalities (Deformity) 04/2022 - 05/2012
7	Infections 01/2022 - 09/2002
7	Hemophilia A (Haemophilia) 01/2022 - 01/2017
6	Hemorrhage 08/2022 - 11/2014
6	Necrosis 01/2020 - 07/2015
5	Scoliosis 02/2014 - 03/2003
4	Inflammation (Inflammations) 03/2021 - 07/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2016
3	Rheumatoid Arthritis 01/2021 - 09/2002
3	Osteoporosis 01/2021 - 07/2015
3	Postoperative Nausea and Vomiting (PONV) 09/2020 - 09/2016
3	Postoperative Pain 01/2020 - 01/2016
2	Venous Thromboembolism 08/2022 - 01/2020
2	Anemia 01/2022 - 03/2012
2	of childhood progressive pseudorheumatoid Arthropathy 06/2021 - 08/2018
2	Knee Osteoarthritis 01/2021 - 10/2020
2	Compression Fractures (Compression Fracture) 01/2021 - 06/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2016
2	Postoperative Hemorrhage 11/2019 - 02/2013
2	Contracture 01/2019 - 05/2012
2	Kyphosis 11/2017 - 12/2012
2	Oncogenic osteomalacia 01/2017 - 07/2015
2	Arthritis (Polyarthritis) 01/2017 - 05/2012
1	Glomus Tumor (Glomus Tumors) 03/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Osteomyelitis 01/2022
1	Skin Ulcer 01/2022
1	Spontaneous Fractures (Pathological Fracture) 01/2022
1	Myocardial Infarction 12/2021
1	Atherosclerosis 12/2021
1	Aneurysm (Aneurysms) 12/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Rare Diseases (Rare Disease) 06/2021
1	Neuromyelitis Optica (Devic's Disease) 01/2021
1	Osteolysis 01/2021

Drug/Important Bio-Agent (IBA)

7	SteroidsIBA 01/2021 - 07/2013
6	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 02/2013
5	MicroRNAs (MicroRNA)IBA 06/2022 - 12/2014
4	Pharmaceutical PreparationsIBA 10/2020 - 07/2015
4	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2016
3	Biological ProductsIBA 11/2021 - 01/2020
3	Circular RNAIBA 03/2020 - 10/2019
3	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2016
2	3,5-tetrahydroaldosterone sulfate (THAS)IBA 10/2022 - 11/2019
2	HydrogelsIBA 03/2022 - 01/2019
2	Therapeutic UsesIBA 12/2021 - 07/2015
2	Long Noncoding RNAIBA 11/2021 - 10/2019
2	Tuberculin (PPD)IBA 06/2021 - 08/2018
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 05/2016
2	GlucocorticoidsIBA 01/2021 - 09/2015
2	Bone Cements (Bone Glue)IBA 01/2021 - 06/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 09/2015
2	Polymethyl Methacrylate (Sol)IBA 01/2021 - 06/2019
2	Celecoxib (Celebrex)FDA Link 01/2020 - 01/2016
2	parecoxibIBA 01/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2002 - 09/2002
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2021
1	Antisense RNA (Anti-Sense RNA)IBA 11/2021
1	CyclinsIBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021
1	Cyclin-Dependent Kinase 4IBA 11/2021
1	Caspase 3 (Caspase-3)IBA 11/2021
1	fibrin fragment D (D-dimer)IBA 05/2021
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Sufentanil (Sufenta)FDA LinkGeneric 10/2020

Therapy/Procedure

25	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 09/2002
15	Therapeutics 03/2022 - 02/2013
11	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2022 - 06/2015
6	Arthroplasty 01/2020 - 03/2012
4	Osteotomy 01/2021 - 05/2012
3	Length of Stay 01/2022 - 09/2016
3	Blood Transfusion (Blood Transfusions) 11/2019 - 03/2012
3	Spinal Fusion (Spondylosyndesis) 01/2014 - 03/2003
2	Prostheses and Implants (Prosthesis) 04/2022 - 09/2002
2	Surgical Amputation (Amputations) 01/2022 - 09/2002
2	Tourniquets 01/2021 - 12/2014
2	Analgesia 10/2020 - 01/2020
2	Ilizarov Technique 01/2019 - 08/2018
2	Arthrodesis 12/2018 - 09/2002
2	Operative Surgical Procedures 12/2018 - 11/2014
2	Replacement Arthroplasty 07/2018 - 06/2015
2	Electrocoagulation (Electrocautery) 01/2018 - 12/2014
2	Conservative Treatment 06/2017 - 05/2012
2	Reoperation 02/2015 - 01/2014
2	Debridement 09/2002 - 09/2002
1	Drug Therapy (Chemotherapy) 01/2021
1	Orthopedic Procedures 01/2021
1	Aftercare (After-Treatment) 12/2020
1	Precision Medicine 12/2020